Dr. Daniele Gilkes is assistant professor of oncology, as well as an assistant professor in chemical and molecular engineering at the Johns Hopkins University School of Medicine.
This is her first year as a BCRF grantee. Dr. Paul Macklin is an associate professor of intelligent systems engineering, and a member of the Melvin & Bren Simon Cancer Center at Indiana University.
He’s a BCRF grantee since 2014. Together, Drs. Gilkes and Macklin are part of a collaboration between the BCRF and JKTG Foundation that links computational scientists with biologists.
They recently talked to BCRF about their efforts to gain new insights into tumor growth, metastasis, and the mechanics of drug resistance.
Featured news
Dedication of the Giovanis Institute for Translational Cell Biology
JKTG Founder and President Ted Giovanis, leading researchers, and University leaders gathered at the Johns Hopkins Welch Medical Library this week to formally mark the dedication of the Giovanis Institute for Translational Cell Biology – a symbolic first step of this important cancer research program.
Ted’s Take: SDOH meet BMI
Social Determinants of Health (SDoH) is all the rage as far as evaluating health. Stable housing, education, access to transportation, polluted water/air, etc. are all an important part of the discussion.
Ted’s Take: TG not in Part C
Medicare Part C, sometimes called Medicare Advantage, is touted as the efficient way to deliver quality care to enrollees. As someone on Medicare, I am not in a Medicare Part C. Why? Because I know better.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133